Seeking Alpha

Theravance Inc. (THRX)

()

News & PR
Market Currents

Buzz
Twitter: THRX

Business Intelligence
Transcripts
Events
Key Developments

Analysis - Latest Articles by most recent | most commented

BioMed Updates: Merck KGaA, BioMarin, Cytori and Theravance

Nov 30 • Mike Havrilla • 2 Comments
Theravance, Inc.: Wait to Buy on Dip

Nov 26 • Penn Bioinvestor • 4 Comments
Seth Klarman's Baupost Group Q3 Portfolio: Two Changes of Note

Nov 17 • Market Folly • 10 Comments
Baupost Group's Massive Position in CapitalSource

Aug 20 • Market Folly • 3 Comments
FDA Calendar: 2H09 Binary Event Trades

Jul 27 • Mike Havrilla • 3 Comments
15 Overvalued Small Caps from Russell 2000

Jul 8 • Value Expectations • 5 Comments
2009 Looking Good for Theravance

Jun 16 • Zacks.com • 1 Comment
FDA Calendar: 18 Hot Summer Trades

Jun 16 • Mike Havrilla • 4 Comments
Klarman's Baupost Group Bets Big on Capitalsource, News Corp.

Jun 1 • Market Folly • Comment!
FDA, Clinical Trial Updates: Pro-Pharma Looks Promising

Apr 26 • Mike Havrilla • 5 Comments
Theravance Narrows Its Losses

Apr 24 • Zacks.com • Comment!
20 'Bathwater Babies' and 15 'Dogs with Fleas' for the Week

Apr 20 • J Clinton Hill • 1 Comment
FDA, Clinical Trial Calendar Updates: Theravance, Gilead, Teva, Alnylam, ReNeuron

Apr 7 • Mike Havrilla • Comment!
Tudor Investment Takes New Positions in Financials, Among Others

Mar 17 • Market Folly • 3 Comments
Hedge Fund Portfolio Tracking: Seth Klarman's Baupost Group, Q4 2008

Mar 3 • Market Folly • Comment!
Updated Clinical Trial Notes on Somaxon, Theravance

Mar 1 • Mike Havrilla • Comment!
Seth Klarman's Best Ideas (for Now)

Feb 20 • The Manual of Ideas • 9 Comments
Eye-Catching Portfolio Moves by Klarman, Witmer and Einhorn

Feb 17 • Davy Bui • 4 Comments
Updated Clinical Trial and FDA Calendars

Jan 29 • Mike Havrilla • 1 Comment
Baupost Group (Seth Klarman): Portfolio Update

Jan 22 • Market Folly • Comment!
Hedge Fund Tracking: Seth Klarman & Baupost Group, Q3 2008

Dec 30, 2008 • Market Folly • 5 Comments
Three-Month, Updated FDA Decision Calendar

Dec 1, 2008 • Mike Havrilla • Comment!
73 Decision Dates on Updated FDA Calendar

Nov 22, 2008 • Mike Havrilla • 4 Comments
15 Value Hedge Funds - Portfolio Update

Aug 21, 2008 • Mebane Faber • 6 Comments
Baupost Group - Portfolio Holdings

May 19, 2008 • Mebane Faber • Comment!
Ten Companies Involved in Treating Asthma

Mar 31, 2008 • Stockerblog • 2 Comments
Tuesday's Options Report: XLF, AIG, ALB, THRX, SGP, CPHD, IGT, PDE

Feb 12, 2008 • Andrew Wilkinson • Comment!
The Long Case for Targanta Therapeutics

Jan 31, 2008 • Andrew Waight • 2 Comments
FDA Sets Date for Theravance Drug Review

Jan 11, 2008 • Brett Scott • Comment!
Top 10 Emerging Biotech Stocks

Oct 15, 2007 • Mike Havrilla • 1 Comment
Biotech Day In Review: Cell Genesys Climbs On GVAX Results

Apr 4, 2007 • Centient Biotech Investor • Comment!
Biotech Day In Review: Genentech Loses Cabilly Patent Ruling

Feb 22, 2007 • Centient Biotech Investor • Comment!
Biotech Stocks Day-in-Review: Amgen Strikes Drug Deal With Cytokinetics

Jan 4, 2007 • Centient Biotech Investor • Comment!

Theravance Inc. (THRX)

Analysis - Latest Articles by most recent | most commented

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers